Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol Pilot for Central Centrifugal Cicatricial Alopecia
NCT05416320Phase 1Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2023
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AKP01 in central centrifugal cicatricial alopecia (CCCA) (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Amount of hairline stabilization at 6 months. Planned start Aug 2023; status: withdrawn.
02
Drugs
AKP01
03
Conditions
central centrifugal cicatricial alopecia (CCCA)
Beyond the preview
Go deeper on NCT05416320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416320.